Invesco India Pharma and Healthcare Fund: Can Investors Benefit from the Growth of the Healthcare Sector?

India’s long-term growth in the pharmaceutical and healthcare sectors is the key investment theme behind the Invesco India Pharma and Healthcare Fund, a new sector-focused equity mutual fund scheme launched by Invesco Mutual Fund. The New Fund Offer (NFO) is open until September 1, 2026. The scheme uses the BSE Healthcare TRI (Total Return Index) as its benchmark.

The fund seeks investment opportunities across various segments of the healthcare sector, including pharmaceuticals, hospitals, diagnostic centres, medical devices, pharmaceutical research, biotechnology and contract manufacturing.

Key Features of the Fund

The scheme is designed to invest 80% to 100% of its portfolio in equity and equity-related instruments of companies belonging to the pharmaceutical and healthcare sectors. The fund may invest in around 40 companies and will look for opportunities across large-cap, mid-cap and small-cap companies.

The investment strategy combines a top-down approach, which identifies healthcare segments with attractive growth potential, with a bottom-up approach, which focuses on selecting individual companies with strong business prospects.

Feature	Details
Fund Name	Invesco India Pharma and Healthcare Fund
Category	Sectoral Equity Fund
NFO Period	Until September 1, 2026
Investment Sector	Pharmaceuticals and Healthcare
Equity Allocation	80%–100%
Benchmark	BSE Healthcare TRI
Company Sizes	Large-cap, Mid-cap and Small-cap
Expected Number of Stocks	Around 40

Why Does the Healthcare Sector Have Potential?

India’s population is increasing, while life expectancy is also rising. This could lead to higher demand for healthcare services over the long term. At the same time, lifestyle-related diseases such as diabetes, heart disease and cancer are becoming increasingly prevalent, which could contribute to higher healthcare expenditure.

The expansion of health insurance coverage could also benefit the sector. As m

ore people gain access to health insurance, demand for quality hospitals, diagnostic services and medical treatments could increase.

Opportunities Beyond Pharmaceuticals

The investment opportunity in this fund is not limited to pharmaceutical companies. It also seeks opportunities in hospitals, diagnostic centres, medical devices and pharmaceutical research companies.

India has established itself as an important global pharmaceutical manufacturing hub, particularly in the production of generic medicines. Indian pharmaceutical companies have opportunities in both domestic and international markets, which could support the sector’s long-term growth.

Hospitals and Medical Devices

The expansion of health insurance, urbanisation and increasing demand for quality healthcare services could create long-term growth opportunities for the hospital sector.

Similarly, growing awareness about early disease detection could increase demand for diagnostic services. Advances in medical technology could also drive demand for various medical devices and equipment.

Who May Consider This Fund?

Investors who have a long-term investment horizon of seven to ten years or more and believe in the long-term growth potential of India’s healthcare sector may consider this fund.

However, the fund may not be suitable for investors who need their money in the short term or those who are uncomfortable with high levels of market volatility.

How Much Can Be Invested?

It is important to keep investments in sector-focused funds within reasonable limits. As a general approach, investors may consider allocating around 5% to 10% of their overall investment portfolio to such sector-specific funds.

For example, if an investor has a total investment portfolio of ₹10 lakh, allocating around ₹50,000 to ₹1 lakh to a healthcare sector fund could be considered, while the remaining amount can be diversified across broader equity funds and other asset classes. This approach can help control concentration risk.

Conclusion

Invesco India Pharma and Healthcare Fund is a sector-focused equity mutual fund that aims to benefit from the long-term growth potential of India’s healthcare sector. Its investment approach extends beyond pharmaceutical companies to include hospitals, diagnostic services, medical devices and other healthcare-related businesses.

India’s growing healthcare expenditure, expanding health insurance coverage, increasing prevalence of lifestyle-related diseases and advances in medical technology could provide long-term growth opportunities for the sector.

However, investors should remember that a sector-focused fund can experience higher volatility because its investments are concentrated in a particular sector. Therefore, it may be more appropriate to consider this fund as a satellite investment alongside a well-diversified core portfolio, rather than as the primary investment for an investor’s entire portfolio.

For more details and invest

Mr. Venkatesan P,

Founder, https://paisacare.in

Mr. Venkatesan P

Founder, PAISACARE FINANCIAL SERVICES, Chennai

Phone number: 98404 22744

Arn 315388

E Mail id: venkat.profit@gmail.com

Web Site: https://paisacare.in

Mr. P.Venkatesan had a 30 years’ experience in Financial Services (Life Insurance, Health Insurance, Mutual Funds etc.)

Office Address:

Paisacare Financial services

No 3B 2nd Street, Sivanandha Nagar

Kolathur, Chennai -600 099

Read articles written by Mr. Mr. P.Venkatesan in Nanayam Vikatan, a leading personal financial management magazine. https://bit.ly/4dSFLxh

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme related documents carefully. The past performance of the mutual funds is not necessarily indicative of future performance of the schemes.